Moderna will begin human trials of an HIV vaccine which uses mRNA technology, the same technology which made their COVID-19 vaccine effective. The trials will end sometime in 2023.
Moderna, the biotech company that developed one of the first COVID-19 vaccines last year, is hoping to break new ground this week in fighting another pandemic: HIV/AIDS.
What people are saying?
Kalob Gossett This week, Moderna will start human trials for its HIV vaccine. It will be the first of its kind to use mRNA, which was used in its effective COVID-19 vaccine. The clinical trials are expected to end in Spring 2023.
J This is so amazing. 37 years of HIV research (immune system + smart virus) made the Covid vaccine possible and the concentrated global funding and collective concern for Covid created the perfect storm for progress towards an HIV vaccine. What a full circle moment for science!